This site is intended for healthcare professionals

BMS announced data at ASH meeting from TRANSCEND NHL 001 study evaluating liso-cel in relapsed or refractory mantle cell lymphoma.

Read time: 1 mins
Last updated:8th Dec 2020
Published:8th Dec 2020
Condition: Mantle Cell Lymphoma
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest